Nitrilotriacetic acid

CAS No. 139-13-9

Nitrilotriacetic acid( —— )

Catalog No. M33692 CAS No. 139-13-9

Nitrilotriacetic acid (Nitriloacetate) is a chelator that tracks and enriches His-tagged proteins in living cells by reacting with divalent metal ions-mediated 6His tagging.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 28 In Stock

Biological Information

  • Product Name
    Nitrilotriacetic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Nitrilotriacetic acid (Nitriloacetate) is a chelator that tracks and enriches His-tagged proteins in living cells by reacting with divalent metal ions-mediated 6His tagging.
  • Description
    Nitrilotriacetic acid is an aminotricarboxylic acid. Nitrilotriacetic acid can be used as a chelating agent, forming coordination compounds with metal ions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    139-13-9
  • Formula Weight
    191.14
  • Molecular Formula
    C6H9NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)CN(CC(=O)O)CC(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Anderson RL, et al. A review of the environmental and mammalian toxicology of nitrilotriacetic acid. Crit Rev Toxicol. 1985;15(1):1-102.?
molnova catalog
related products
  • Dasatinib carbaldehy...

    Dasatinib carbaldehyde (PROTAC ABL binding moiety 4) is based on Dasatinib which is an ABL inhibitor, binds to the IAP ligand via a linker, and forms SNIPER .

  • tafamidis meglumine

    Tafamidis meglumine is a Potent and Selective Transthyretin Kinetic Stabilizer That Inhibits the Amyloid Cascade.

  • EC5026

    EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators.?EC5026 (BPN-19186) is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism of membrane fatty acids.?Inhibition of sEH treats pain by stabilizing natural analgesic and anti-inflammatory mediators.